Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/059147external-prioritypatent/WO2012159960A1/en
Application filed by Aventis Pharma IncfiledCriticalAventis Pharma Inc
Publication of TN2013000470A1publicationCriticalpatent/TN2013000470A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a pharmaceutical formulation of fexofenadine hydrochloride in a solvent system suitable as a liquid fill composition. In another aspect, the invention also relates to a process for the preparation of the said pharmaceutical formulation and the use of said composition for the preparation of a drug for the treatment of allergic reactions in a patient.
C0mpounds as modulators of atp-binding cassette transporters, pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating diseases and processes for preparation thereof
Substituted aminobutyric derivatives as neprilysin inhibitors, process for their preparation, pharmaceutical compositions comprising them and use thereof for preparation of medicaments
Compounds and compositions as c-kit kinase inhibitors, pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating diseases
Pyrazoloquinolines and intermediate compounds, process for their preparation, use thereof and medicaments and pharmaceutical compositions comprising them
Cyclic azaindole-3-carboxamides, process for their preparation, pharmaceutical compositions comprising them and their use for manufacture of medicaments
Composition for preventing or treating eye diseases, containing s-allyl-l-cysteine as active ingredient, and pharmaceutical formulation containing same